P05771 |
KPCB_HUMAN |
Brain cancer [ICD-11: 2A00] |
P05771 |
KPCB_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P05771 |
KPCB_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P05771 |
KPCB_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P05771 |
KPCB_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P05771 |
KPCB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05771 |
KPCB_HUMAN |
Transplant rejection [ICD-11: NE84] |
P05771 |
KPCB_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P05771 |
KPCB_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P05771 |
KPCB_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02156 |
KPCE_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q02156 |
KPCE_HUMAN |
Liver vascular disorder [ICD-11: DB98] |
Q02156 |
KPCE_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
Q02156 |
KPCE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q02156 |
KPCE_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q02156 |
KPCE_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q96RI1 |
NR1H4_HUMAN |
Autoimmune liver disease [ICD-11: DB96] |
Q96RI1 |
NR1H4_HUMAN |
Cholelithiasis [ICD-11: DC11] |
Q96RI1 |
NR1H4_HUMAN |
Insomnia [ICD-11: 7A00-7A0Z] |
Q96RI1 |
NR1H4_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
Q96RI1 |
NR1H4_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96RI1 |
NR1H4_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q96RI1 |
NR1H4_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
Q96RI1 |
NR1H4_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
Q96RI1 |
NR1H4_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q96RI1 |
NR1H4_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q96RI1 |
NR1H4_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 |
GPBAR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 |
GPBAR_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q8TDU6 |
GPBAR_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |